Pioneering Stem Cell Therapy Players in Market, 2022

Haven’t we all heard about stem cells in the news, and possibly you've questioned if they may be helpful to you or a dear one suffering from a grave ailment. You may also wonder what stem cells are and how they are being utilized to cure serious conditions and injury, and why they are a topic of such vital conversation.

Here are a few answers to regularly asked queries about stem cells.

What are stem cells?

Stem cells are the body's raw resources; the root cells from where all other cells with specific functions are sprouted. Under the appropriate circumstances in the body or a laboratory, stem cells split to generate more cells known as daughter cells.

COVID-19 Impact on the Industry

The development of the stem cell therapy industry is accredited to the growing number of medical trials and the increasing adoption of stem cell therapy across the globe. In the perspective of COVID-19, government establishments in numerous nations, research bodies, and various biotech and pharmaceutical companies are concentrating on operative and prompt technologies for a quick analysis of COVID-19. As per a research article published in 2020 in the scientific paper Aging and Disease (2020), mesenchymal stem cells are benign and can be an operative method toward the treatment of COVID-19.

Business Research Insights states that the global stem cell therapy market size was USD 493.4 million in 2021 and market is projected to touch USD 1652.9 million by 2028, at a CAGR of 18.9%.

Below mentioned are the top 8 stem cell therapy players operating in the market.

1. Osiris Therapeutics

Osiris Therapeutics, Inc. was founded in March 1993 succeeding the identification of MSCs by Dr. Arnold Caplan and his associates at Case Western Reserve University, located in Cleveland Ohio. Moreover, Dr. Caplan licensed the technology and united with Kevin Kimberlin and Peter Friedli to unveil Osiris.

2. NuVasive

NuVasive is a medical devices corporation located in San Diego, California. The company predominantly produces medical devices and techniques for minimally invasive spine operation. NuVasive was inaugurated in July 1997 as a medical device corporation based in San Diego, California.

3. JCR Pharmaceutical Co. Ltd.

JCR Pharmaceuticals Co., Ltd. creates, manufactures, and sells pharmaceutical products and raw supplies. The company also retails apparatus for hospital and laboratory applications. Its products involve drugs for leukemia and hormonal agents comprising genetically created human somatotrophic hormone (growth hormone) as well as gonadotropic hormone.

4. Pharmicell Co. Ltd.

Pharmicell Co. Ltd. is a biotechnology corporation. Its business expertise comprises stem cell therapeutics, stem cell banking, bio-based operations as well as cosmetics. Pharmicell Co. Ltd. (Pharmicell), previously known as Yuhaw Trade Co. Ltd., is a pharma-based company that determines, advances, and markets stem cell drugs.

5. MEDIPOST

From the beginning of its foundation in 2000, MEDIPOST has been taking robust decisions in spite of the complications and problems in the sector of stem cell research and commercialization while safeguarding corporate morals and standards.

MEDIPOST assembles, processes, and conserves umbilical cord blood. The company's facilities permit the impending latent usage of stem cell treatment for both, clients' own relatives as well as public usage. The company’s objective is to assist patients with incurable ailments and unravel unmet clinical requirements through stem cells and regenerative medication.

6. Anterogen Co. Ltd.

Anterogen Co., Ltd. is a biotechnology corporation that examines and improves stem cell therapy products and orphan drugs utilizing adult stem cells. Its chief products include Cupistem, Adipocell, and Queencell.

7. MOLMED

MOLMED is a biotechnology corporation founded in 1996 and based in Milan. It formerly functioned as a contract production establishment and other facilities for companies advancing gene therapy and stem cell therapy products. In 2000, the company altered its business model and began to create products of its own.

8. Takeda (TiGenix)

Takeda is a Japan-based multinational pharmaceutical corporation, with partial American and British roots. It is the biggest pharmaceutical corporation in Asia and among the key 20 biggest pharmaceutical corporations across the globe by revenue. The company has more than 49,578 employees across the world and gained USD 19.29 billion in revenue during the 2018 financial year.

Applications of Stem Cells

The area of stem cell-based therapies gathers substantial investments, and numerous medical trials that necessitate significant backing for spending are presently scheduled. Corporations are raising funds to improve stem cell-based therapies to solve problems pertaining to several clinical conditions.

Stem cells are predominantly utilized in reformative medicine, particularly in the sector of dermatology. Nevertheless, oncology is anticipated to develop at the highest rate, owing to a huge number of pipeline products present for the treatment of tumors or cancers. Along with the rise in the number of regenerative medicine facilities, the market is also foreseen to expand in future.